MABVAX THERAPEUTICS HLDGS IN's ticker is MBVX and the CUSIP is 55414P504. A total of 10 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 3,058,703 | $2,141,000 | 0.02% |
| Biomark Capital Management Co. LLC | 26,708 | $19,000 | 0.02% |
| Delaney Dennis R | 10,000 | $7,000 | 0.01% |
| Bison Wealth, LLC | 15,000 | $11,000 | 0.01% |
| Virtu Financial LLC | 99,114 | $69,000 | 0.00% |
| BRIGHTON JONES LLC | 10,000 | $7,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 18,996 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 3 | $0 | 0.00% |
| Brinker Capital Investments, LLC | 1,000 | $1,000 | 0.00% |